Multidrug-resistant infections

Small Animal Critical Care Medicine, Second Edition

Volumn , Issue , 2014, Pages 537-540

  Epstein, Steven ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84987796854     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-0306-7.00103-3     Document Type: Chapter

References (35)

1. Archibald L, Phillips L, Monnet D et al. Antimicrobial resistance in isolates from in-patients nd outpatients in the United States: increasing importance of the intensive care unit Clin Infect Dis 24 1997 211
2. Badal RE, Bouchillon SK, Lob SH et al. Etiology, extended-spectrum β-lactamase rates and antimicrobial susceptibility of gram-negative bacilli causing intra-abdominal infections in patients in general pediatric and pediatric intensive care units-global data from the study for monitoring antimicrobial resistance trends from 2008 to 2010 Pediatr Infect Dis J 32 2013 636
3. Black DM, Rankin SC, King LG Antimicrobial therapy and aerobic bacteriologic culture patterns in canine intensive care unit patients: 74 dogs (January-June 2006) J Vet Emerg Crit Care 19 2009 489
4. Ogeer-Gyles J, Mathews K, Sears W et al. Development of antimicrobial drug resistance in rectal Escherichia coli isolates from dogs hospitalized in an intensive care unit J Am Vet Med Assoc 229 2006 694
5. Ghosh A, Dowd SE, Zurek L Dogs leaving the ICU carry a very large multi-drug resistant enterococcal population with the capacity for biofilm formation and horizontal gene transfer PLoS ONE 6 2011 e22451
6. Hamilton E, Kaneene JB, May KJ et al. Prevalence and antimicrobial resistance of Enterococcus spp and Staphylococcus spp isolated from surfaces in a veterinary teaching hospital J Am Vet Med Assoc 240 2012 1463
7. Kukanich KS, Ghosh A, Skarbek JV et al. Surveillance of bacterial contamination in small animal veterinary hospitals with special focus on antimicrobial resistance and virulence traits of enterococci J Am Vet Med Assoc 240 2012 437
8. Julian T, Singh A, Rousseau J et al. Methicillin-resistant staphylococcal contamination of cellular phones of personnel in a veterinary teaching hospital BMC Res Notes 5 2012 193
9. Baker SA, Ban-Balen J, Lu B et al. Antimicrobial drug use in dogs prior to admission to a veterinary teaching hospital J Am Vet Med Assoc 241 2012 210
10. Magiorakos AP, Srinivasan A, Carey RB et al. Multi-drug resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 18 2012 268
11. Maragakis LL Recognition and prevention of multidrug-resistant gram-negative bacteria in the intensive care unit Crit Care Med 38 2010 s345
12. Lin MY, Hayden MK Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: recognition and prevention in intensive care units Crit Care Med 38 2010 s335
13. Ogeer-Gyles JS, Mathews KA, Boerlin P Nosocomial infections and antimicrobial resistance in critical care medicine J Vet Emerg Crit Care 16 2006 1
14. Epstein SE, Mellema MS, Hopper K Airway microbial culture and susceptibility patterns in dogs and cats with respiratory disease of varying severity J Vet Emerg Crit Care 20 2010 587
15. Gibson JS, Morton JM, Cobbold RN et al. Multi-drug resistant E. coli and Enterobacter extraintestinal infection in 37 dogs J Vet Int Med 22 2008 844
16. Gibson JS, Morton HM, Cobbold RN et al. Risk factors for multidrug-resistant Escherichia coli rectal colonization of dogs on admission to a veterinary hospital Epidemiol Infect 139 2011 197
17. American Thoracic Society Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Resp Crit Care Med 171 2005 388
18. Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock Intens Care Med 39 2013 165
19. Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 2006 1589
20. Joung MK, Lee J, Moon S et al. Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia Crit Care 15 2011 R79
21. Gonzalez L, Cravoisy A, Barraud D et al. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients Crit Care 17 2013 R140
22. Morel J, Casoetto J, Jospe R et al. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit Crit Care 14 2010 R225
23. Bemis DA, Jones RD, Frank LA et al. Evaluation of susceptibility rest breakpoints used to predict mecA-mediated resistance in Staphylococcus pseudintermedius isolated from dogs J Vet Diagn Invest 21 2009 53
24. Rybak MJ, Lomaestro BM, Rotscahfer JC et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases society of America, the American society of health-system pharmacists, and the society of infectious diseases pharmacists Clin Infect Dis 49 2009 325
25. Hayakawa K, Marchaim D, Palla M et al. Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study Antimicrob Agents Chemother 57 2013 49
26. Fridkin SK, Edwards JR, Courval JM et al. The effect of vancomycin and third-generation cephalosporin’s on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units Ann Intern Med 135 2001 175
27. Chatterjee I, Iredell JR, Woods M et al. The implications of enterococci for the intensive care unit Crit Care Resusc 9 2007 69
28. Arias CA, Contreras GA, Murray BE Management of multidrug-resistant enterococcal infections Clin Microbial Infect 16 2010 555
29. Koutsogiannou M, Drougka E, Liakopoulos A et al. Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital J Clin Microbiol 51 2013 665
30. Zhanel GG, Adam JH, Baxter MR et al. Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-2011 study J Antimicrob Chemother 68 suppl 2013 i7
31. Ong DS, Jongerden IP, Buiting AG et al. Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units Crit Care Med 39 2011 2458
32. Carmeli Y, Troillet N, Eliopoulos GM et al. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents Antimicrob Agents Chemother 43 1999 1279
33. Walkty A, DeCorby M, Nichol K et al. In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals of the CANWARD study, 2007-2008 Antimicrob Agents Chemother 53 2009 4924
34. Bratu S, Tolany P, Karumudi U et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents J Antimicrob Chemother 53 2005 5046
35. Endimiani A, Huger AM, Perez F et al. Characterization of blaKPC-containing Klebsiella pneumoniae: isolates detected in different institutions in the eastern USA J Antimicrob Chemother 63 2009 427